Pilot Study to Evaluate the Efficacy and Safety of Quetiapine Fumarate Instant-Release (Seroquel IR) in Controlling Agitation and Aggressive Symptoms in the Acute Treatment of Patients With Schizophrenia

NCT00838032 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Acute Schizophrenia

Interventions

DRUG: Quetiapine fumarate
DRUG: Haloperidol

Sponsor

Sichuan University